RIVERSIDE, Calif. — Size does not matter. Certainly not when it comes to tiny wo...
“Pazopanib is a multi-kinase inhibitor that is currently approved for treatment ...
Changes to DNA, known as mutations, can increase the likelihood of developing ca...
LEXINGTON, Ky. (Jan. 12, 2024) — Larry Goldstein, M.D., chair of the University ...
LEXINGTON, Ky. (Jan. 12, 2024) — The University of Kentucky will mark a decade o...
China has officially granted approval for the sale of Leqembi, a revolutionary A...
Researchers from Harvard University and the Broad Institute, led by Dr. David Li...
GSK has revealed a contract to acquire Aiolos Bio and its phase 2 asthma medicin...
3M Health Care has received a $34.2m award to improve the treatment of traumatic...
GSK has gained approval from the China National Medical Products Administration ...
Myrobalan Therapeutics has secured $24m in a Series A funding round to develop C...
Oratrope is a small molecule commercialized by Lumos Pharma, with a leading Phas...
Though not approved in the US, Laboratoires Delbert’s extencilline will be the a...
Mirati filed a marketing authorisation application to the EMA for Krazati for pa...
Innovent has reported positive Phase III results for mazdutide, Eli Lilly’s next...
Expanded patient groups at risk of progression to severe Covid-19 will be eligib...
